RGNX
Regenxbio Inc
7.20$
-3.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.4% | +9.6% | -9.5% | -8.8% | -10.2% | +5.4% | +18.4% | -9.6% | -13.7% | -24.5% | +13.1% | |
| – | -8.4% | +18.0% | -12.3% | -9.6% | -11.3% | +12.7% | +19.3% | -11.2% | -15.3% | -33.7% | +26.6% | |
| – | -34.9% | +227.3% | -48.9% | -2.0% | +1.6% | +126.2% | -38.9% | -26.1% | -41.4% | -55.8% | +139.6% | |
| – | -8.8% | +23.0% | -14.3% | -12.0% | -8.1% | +14.1% | +20.7% | -15.2% | -16.1% | -34.6% | -29.9% | |
| – | -16.9% | -34.2% | +39.7% | +4.1% | -14.4% | -11.2% | +12.2% | +23.2% | +3.5% | -60.0% | +875.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.1% | -9.0% | -7.3% | -1.5% | -5.2% | +5.0% | +69.5% | -1.0% | -3.7% | -8.4% | -1.9% | |
| – | +2.3% | -15.4% | -10.8% | +4.5% | +0.5% | +3.4% | +12.0% | +4.2% | -5.2% | -39.8% | +16.2% | |
| – | +6.5% | +546.3% | -13.7% | -80.4% | +2.4% | +0.5% | +1.3% | +531.0% | -5.7% | -83.6% | -6.5% | |
| – | +4.2% | +37.6% | -47.8% | +19.3% | +16.8% | -16.5% | +13.7% | +2.8% | -4.1% | -0.7% | -26.7% | |
| – | -14.1% | +25.3% | -10.9% | -13.5% | -13.9% | +5.6% | -22.1% | -24.4% | -36.4% | -79.5% | +240.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +3.9% | +10.6% | +0.4% | +0.1% | +1.1% | +0.1% | +0.4% | +0.1% | +1.3% | +1.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.